Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net (loss)	$ (732,000)	$ (1,237,000)
Adjustments to reconcile net (loss) to net cash provided by operating activities:
Depreciation and amortization	30,912,000	30,558,000
Provision for impairment	250,000
Gain on land condemnation	(69,000)
Amortization of deferred rent receivables/liabilities, net	(614,000)	(711,000)
Amortization of above/below-market lease intangibles, net	(1,950,000)	(1,782,000)
Amortization of assumed below/above-market debt, net	2,897,000	2,253,000
Amortization of lease incentives	194,000	169,000
Amortization of deferred financing costs	342,000	355,000
Amortization of deferred ground rent	121,000	121,000
Changes in assets and liabilities, net of assets acquired and liabilities assumed:
Receivables	130,000	(480,000)
Other assets	(280,000)	239,000
Due from affiliates	536,000	(263,000)
Accounts payable, accrued expenses and other liabilities	1,106,000	1,683,000
Due to affiliates	169,000	20,000
Net cash provided by operating activities	33,012,000	30,925,000
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisitions of real estate	(10,218,000)	(24,643,000)
Proceeds from land condemnation	122,000
Improvements of real estate	(564,000)	(692,000)
Advances on notes receivable from affiliated parties	(2,000)	(8,000)
Advances on RSLCA notes receivable from affiliated party	(99,120,000)	(62,789,000)
Net cash used in investing activities	(30,418,000)	(17,876,000)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of common shares	28,788,000	32,743,000
Offering costs from issuance of common shares	(1,149,000)	(1,601,000)
Repurchases of common shares	(17,541,000)	(8,439,000)
Offering costs from issuance of noncontrolling interests		(260,000)
Proceeds from pending trade deposits	1,700,000	1,153,000
Proceeds from mortgage loans payable		65,430,000
Repayments of mortgage loans payable	(28,839,000)	(14,332,000)
Proceeds from revolving credit facilities	59,000,000
Repayments of revolving credit facilities	(15,000,000)	(73,311,000)
Payments of financing costs	(1,161,000)	(781,000)
Common shares distributions	(17,971,000)	(19,589,000)
Noncontrolling interests distributions	(10,046,000)	(9,810,000)
Net cash used in financing activities	(2,219,000)	(28,797,000)
Net increase (decrease) in cash, cash equivalents and restricted cash	375,000	(15,748,000)
Cash, cash equivalents and restricted cash at beginning of year	19,329,000	36,645,000
Cash, cash equivalents and restricted cash at end of period	19,704,000	20,897,000
Reconciliation to consolidated balance sheets:
Cash and cash equivalents	8,096,000	6,549,000
Restricted cash	11,608,000	14,348,000
Cash, cash equivalents and restricted cash at end of period	19,704,000	20,897,000
Supplemental disclosures of cash flow information:
Cash paid for interest	20,415,000	18,903,000
Supplemental disclosures of non-cash investing and financing activities:
Distributions payable	3,529,000	3,434,000
Distributions reinvested into Class A and Class I common shares	3,226,000
Conversion of OP Units to Class I common shares	2,286,000	2,550,000
Assumption of loans payable in conjunction with the acquisition of real estate		43,522,000
Issuance of noncontrolling interest in conjunction with the acquisition of real estate		17,855,000
RSLCA Notes
CASH FLOWS FROM INVESTING ACTIVITIES
Repayments on RSLCA notes receivable from affiliated party	$ 79,364,000	$ 70,256,000